Harvard Apparatus Regenerative Technology(HRGN)
$1.98-0.00 (-0.25%)
HRGN
Harvard Apparatus Regenerative Technology financials statements
$1.98
At close:-0.00 (-0.25%)
Want to see HRGN full AI Analyst Report?
Harvard Apparatus Regenerative Technology (HRGN) Ratios
106 Followers
Harvard Apparatus Regenerative Technology Ratios
HRGN's free cash flow for Q3 2026 was $-621.00K. For the 2026 fiscal year, HRGN's free cash flow was increased by $0.00 and operating cash flow was $-621.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.19 | 3.17 | 0.81 | 1.17 | 0.40 |
| Quick Ratio | 1.18 | 3.09 | 0.76 | 1.17 | 0.40 |
| Cash Ratio | 0.88 | 2.43 | 0.45 | 0.91 | 0.38 |
| Solvency Ratio | -4.18 | -6.20 | -9.32 | -4.27 | -1.68 |
| Operating Cash Flow Ratio | -2.50 | -4.75 | -7.17 | -3.75 | -0.81 |
| Short-Term Operating Cash Flow Coverage | -33.88 | -51.07 | 0.00 | -51.58 | -23.89 |
| Net Current Asset Value | $ 209.00K | $ 2.01M | $ -185.00K | $ 183.00K | $ -3.60M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.07 | 0.02 | 0.06 | 0.09 |
| Debt-to-Equity Ratio | 0.19 | 0.09 | 0.03 | 0.15 | -0.06 |
| Debt-to-Capital Ratio | 0.16 | 0.08 | 0.03 | 0.13 | -0.06 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.06 | 0.00 | 0.05 | -0.02 |
| Financial Leverage Ratio | 2.53 | 1.38 | 1.59 | 2.43 | -0.62 |
| Debt Service Coverage Ratio | -55.85 | -61.32 | -649.50 | -61.19 | -76.04 |
| Interest Coverage Ratio | -952.38 | -214.63 | -649.50 | -61.53 | 0.00 |
| Debt to Market Cap | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
| Interest Debt Per Share | 0.01 | 0.02 | 0.00 | 0.02 | 0.02 |
| Net Debt to EBITDA | 0.17 | 0.27 | 0.04 | 0.18 | 0.12 |
| Profitability Margins | |||||
| Gross Profit Margin | 8.24% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -974.57% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -959.94% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -1082.24% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -975.71% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -975.71% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -975.71% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 90.16% | 94.80% | 99.22% | 98.70% | 92.38% |
| Return on Assets (ROA) | -256.59% | -174.07% | -345.14% | -253.04% | -427.55% |
| Return on Equity (ROE) | -649.86% | -239.98% | -548.12% | -614.05% | 263.39% |
| Return on Capital Employed (ROCE) | -666.58% | -238.41% | -552.43% | -593.35% | 623.99% |
| Return on Invested Capital (ROIC) | -606.61% | -231.97% | -536.78% | -541.64% | 632.83% |
| Return on Tangible Assets | -256.59% | -174.07% | -345.14% | -253.04% | -427.55% |
| Earnings Yield | -22.60% | -17.54% | -13.44% | -9.73% | -34.47% |
| Efficiency Ratios | |||||
| Receivables Turnover | 44.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 1.42 | 0.60 | 0.05 | 0.00 | 0.00 |
| Inventory Turnover | 40.38 | 3.38 | 0.48 | 0.00 | 0.00 |
| Fixed Asset Turnover | 3.50 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.56 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -239.18 | -502.89 | -6007.29 | 0.00 | 0.00 |
| Days of Sales Outstanding | 8.30 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 9.04 | 108.15 | 760.42 | 0.00 | 0.00 |
| Days of Payables Outstanding | 256.52 | 611.04 | 6767.71 | 0.00 | 0.00 |
| Operating Cycle | 17.34 | 108.15 | 760.42 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.23 | -0.33 | -0.52 | -0.45 | -0.26 |
| Free Cash Flow Per Share | -0.23 | -0.33 | -0.52 | -0.45 | -0.26 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -630.82 | -1021.20 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -630.82 | -1021.20 | 0.00 |
| Operating Cash Flow Coverage Ratio | -19.24 | -16.50 | -144.56 | -34.73 | -15.55 |
| Operating Cash Flow to Sales Ratio | -5.44 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -12.60% | -11.01% | -10.35% | -8.19% | -11.36% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.38 | -5.73 | -7.44 | -10.28 | -2.90 |
| Price-to-Sales (P/S) Ratio | 43.17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 28.75 | 13.68 | 40.79 | 63.12 | -7.64 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -7.94 | -9.08 | -9.66 | -12.21 | -8.81 |
| Price-to-Operating Cash Flow Ratio | -7.94 | -9.08 | -9.68 | -12.23 | -8.81 |
| Price-to-Earnings Growth (PEG) Ratio | 0.23 | 0.26 | -0.34 | 0.40 | -0.08 |
| Enterprise Value Multiple | -4.33 | -5.13 | -7.34 | -10.35 | -2.48 |
| Enterprise Value | 29.24M | 41.88M | 66.76M | 61.33M | 22.07M |
| EV to EBITDA | -4.33 | -5.13 | -7.34 | -10.35 | -2.48 |
| EV to Sales | 41.53 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -7.64 | -8.63 | -9.61 | -12.00 | -8.40 |
| EV to Operating Cash Flow | -7.64 | -8.63 | -9.62 | -12.01 | -8.40 |
| Tangible Book Value Per Share | 0.06 | 0.22 | 0.12 | 0.09 | -0.30 |
| Shareholders’ Equity Per Share | 0.06 | 0.22 | 0.12 | 0.09 | -0.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -1.03 | 0.07 |
| Revenue Per Share | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.42 | -0.52 | -0.67 | -0.54 | -0.79 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.01 | 1.02 | 0.92 |
| Research & Development to Revenue | 3.77 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 6.14 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 2.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.56 | 0.63 | 0.77 | 0.84 | 0.33 |
Currency in USD

